Acumen Pharmaceuticals Inc. Made Headway

Wed, Sep 28, 2022 at 07:40 PM
Acumen Pharmaceuticals Inc. Made Headway

Acumen Pharmaceuticals Inc. (ABOS:NASDAQ) rocketted at $9.58, a gain of 103.8%. On Wed, Sep 28, 2022, ABOS:NASDAQ hit a New 2-Week High of $9.58. The stock appeared on our News Catalysts scanner on Thu, Sep 08, 2022 at 01:26 PM in the 'MISCELLANEOUS' category. From Wed, Sep 14, 2022, the stock recorded 30.00% Up Days and 45.45% Green Days

About Acumen Pharmaceuticals Inc. (ABOS:NASDAQ)

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.